1. Catalog
  2. GRBIOMEM2502 - CMLE - Understanding and Applying C ...
Image For Activity Cover
GRBIOMEM2502 - CMLE - Understanding and Applying Cancer Biomarkers in Clinical Decision Making
Course Description

Understanding and Applying Cancer Biomarkers in Clinical Decision Making 

This is module two of six core modules for the Biomarker Testing Navigation Certificate program.  This online, interactive module provides an introduction to precision medicine and personalized cancer care. . 

Course topics include: 

  • Types of cancer biomarkers (e.g., diagnostic, prognostic, predictive)  

  • Tumor classification vs molecular classification of cancer  

  • Solid tumor vs hematologic malignancies 

  • Testing platforms and technologies  

  • Common examples of biomarkers  

  • Cancer susceptibility genes 

Target Audience 
This activity has been designed to meet the educational needs of pathologists and laboratory professionals 

Faculty/Authors

Rachel Starks, MD, Ph. D
Clinical Assistant Professor, Pathology, University of South Dakota Sanford School of Medicine
Sioux Falls, SD 

Physician's Competency: Patient Care, Medical Knowledge 

CME/CMLE Credit: 1.0
Estimated Completion Time: 1.0 hour
Format: Online educational activity

Credit Designation Statement

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.   

ASCP designates this activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel. 

For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time 

Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CMLE certificates will be provided online. 

Commercial Support 
This activity is supported by a sponsorship from AstraZeneca. 


Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 6/10/2025     
Review Date:
Expiration Date: 6/10/2028       




Course Objectives

Upon completion of this activity, you will be able to:

  • Differentiate between diagnostic, prognostic, and predictive cancer biomarkers and their roles in clinical decision making 

  • Compare tumor classification based on histological versus molecular characteristics, including differences between solid tumors and hematologic malignancies. 

  • Evaluate common testing platforms and their applications in cancer biomarker analysis 

  • Describe the clinical significance of cancer susceptibility genes in risk assessment and preventative strategies 

  • Apply knowledge of specific predictive cancer biomarkers to guide treatment decisions for solid tumors and hematologic malignancies 


  

 
Summary
Availability:
On-Demand
Credit Offered:
1 CMLE Credit
Powered By